Abstract:The cyclic GMP-AMP synthase (cGAS) protein is a pattern-recognition receptor of the mammalian innate immune system that is recognized as a main cytosolic sensor of pathogenic or damaged DNA. cGAS DNA binding initiates catalytic production of the second messenger, cyclic GMP-AMP, which activates the STING-TBK1-IRF3 signaling axis to induce cytokine expression. Post-translational modification (PTM) has started to be recognized as a critical component of cGAS regulation, yet the extent of these modifications remains unclear. Here, we report the identification and functional analysis of cGAS phosphorylations and acetylations in several cell types under basal and immune-stimulated conditions. cGAS was enriched by immunoaffinity purification from human primary fibroblasts prior to and after infection with herpes simplex virus type 1 (HSV-1), as well as from immune-stimulated STING-HEK293T cells. Six phosphorylations and eight acetylations were detected, of which eight PTMs were not previously documented. PTMs were validated by parallel reaction monitoring (PRM) mass spectrometry in fibroblasts, HEK293T cells, and THP-1 macrophage-like cells. Primary sequence and structural analysis of cGAS highlighted a subset of PTM sites with elevated surface accessibility and high evolutionary sequence conservation. To assess the functional relevance of each PTM, we generated a series of single-point cGAS mutations. Stable cell lines were constructed to express cGAS with amino acid substitutions that prevented phosphorylation (Ser-to-Ala) and acetylation (Lys-to-Arg) or that mimicked the modification state (Ser-to-Asp and Lys-to-Gln). cGAS-dependent apoptotic and immune signaling activities were then assessed for each mutation. Our results show that acetyl-mimic mutations at Lys384 and Lys414 inhibit the ability of cGAS to induce apoptosis. In contrast, the Lys198 acetyl-mimic mutation increased cGAS-dependent interferon signaling when compared with the unmodified charge-mimic. Moreover, targeted PRM quantification showed that Lys198 acetylation is decreased upon infections with two herpesviruses-HSV-1 and human cytomegalovirus (HCMV), highlighting this residue as a regulatory point during virus infection.

Structure of the Human cGAS–DNA Complex Reveals Enhanced Control of Immune Surveillance

Human Cgas Catalytic Domain Has an Additional DNA-binding Interface That Enhances Enzymatic Activity and Liquid-Phase Condensation.

Structural Basis for Nucleosome-Mediated Inhibition of Cgas Activity

Cytosolic DNA sensing by cGAS: regulation, function, and human diseases

Cyclic GMP-AMP Synthase is Activated by Double-Stranded DNA-Induced Oligomerization

The Molecular Basis of Tight Nuclear Tethering and Inactivation of Cgas

DNA mechanical flexibility controls DNA potential to activate cGAS-mediated immune surveillance

Investigating the Activation Mechanism Differences between Human and Mouse cGAS by Molecular Dynamics Simulations

Nonspecific DNA Binding of Cgas N Terminus Promotes Cgas Activation

Dimerization-dependent gel-like condensation with dsDNA underpins the activation of human cGAS

The DNA Sensor cGAS is Decorated by Acetylation and Phosphorylation Modifications in the Context of Immune Signaling

Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing

Role of Post-Translational Modifications of cGAS in Innate Immunity

cGAS in action: Expanding roles in immunity and inflammation

USP15 promotes cGAS activation through deubiquitylation and liquid condensation

Cellular functions of cGAS-STING signaling

Discovery of Small Molecule Cyclic GMP-AMP Synthase Inhibitors.

A microscopy reporter for cGAMP reveals rare cGAS activation following DNA damage, and a lack of correlation with micronuclear cGAS enrichment

cGLRs are a diverse family of pattern recognition receptors in animal innate immunity

Glutamylation of the DNA Sensor Cgas Regulates Its Binding and Synthase Activity in Antiviral Immunity

Development of Human Cgas-Specific Small-Molecule Inhibitors for Repression of Dsdna-Triggered Interferon Expression